BCG immunotherapy--from pathophysiology to clinical practice.
about
Specific and randomly derived immunoactive peptide mimotopes of mycobacterial antigensImmunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF.Rebuilding immunity in cancer patients.Case: Bacillus Calmette-Guerin (BCG)-induced Reiter syndrome with an attempt at repeat BCG induction.
P2860
BCG immunotherapy--from pathophysiology to clinical practice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
BCG immunotherapy--from pathophysiology to clinical practice.
@ast
BCG immunotherapy--from pathophysiology to clinical practice.
@en
type
label
BCG immunotherapy--from pathophysiology to clinical practice.
@ast
BCG immunotherapy--from pathophysiology to clinical practice.
@en
prefLabel
BCG immunotherapy--from pathophysiology to clinical practice.
@ast
BCG immunotherapy--from pathophysiology to clinical practice.
@en
P2860
P356
P1476
BCG immunotherapy--from pathophysiology to clinical practice.
@en
P2093
Moshe Tishler
P2860
P304
P356
10.1517/14740338.5.2.225
P407
P577
2006-03-01T00:00:00Z